LENCADOPA, LEVOCARBAMET, LEVODOPA/CARBIDOPA GPPL, LEVOCARBAMET, LEVODOPA/CARBIDOPA GXP, APO-LEVODOPA/CARBIDOPA, LEVODOPA/CARBIDOPA GENPAR (Generic Partners Pty Ltd)
Product name
LENCADOPA, LEVOCARBAMET, LEVODOPA/CARBIDOPA GPPL, LEVOCARBAMET, LEVODOPA/CARBIDOPA GXP, APO-LEVODOPA/CARBIDOPA, LEVODOPA/CARBIDOPA GENPAR
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
232 working days (255)
Active ingredients
levodopa / carbidopa
Registration type
New generic medicine
Indication
LEVODOPA, CARBIDOPA (tablets) is indicated for the treatment of Parkinson's disease and syndrome.